Financing will fund growth and expansion of new functional single-cell analysis and sorting product lines for drug discovery, enabled by Partillion’s proprietary Nanovial technology. LOS ANGELES – Partillion Bioscience Corporation (“Partillion”), a life science tools company, today announced the closing of a $5 million seed financing round, expansion of its board of directors, and a multiyear […]

Zoic Capital … funds medical technologies with the ability to improve life. ChromaTan’s bioprocessing purification systems will usher in a new lean, agile, and efficient generation of medicine.” – Neal Mody, Zoic Capital SEATTLE, WA, USA — Zoic Capital , a Seattle-based med-tech investment firm, has participated in a new round of funding for ChromaTan . […]

Funds to support further development and commercialization of the Company’s INDUCE-seq DNA break mapping technology Platform technology provides in situ off-target measurement in clinically relevant cells to accelerate the progression of cell and gene therapy programs New investors include Illumina Ventures, Mérieux Equity Partners, and HERAN Partners Cambridge, UK: Broken String Biosciences (“Broken String”), a genomics company […]

COPENHAGEN, Denmark — Novo Holdings, a leading international life science investor, today announced a $40m investment in Evosep, the bioscience company leading the standardisation of proteomics for clinical use. The proceeds from the investment by Novo Holdings will be used to advance clinical applications of proteomics enabled by Evosep’s standardised liquid chromatography platform. The new funds will […]

The University of Birmingham spinout has secured £487k of equity investment to develop its new class of fluorescent dyes for flow cytometry. University of Birmingham spinout ChromaTwist Ltd has secured £487k of equity investment to develop its new class of fluorescent dyes for the flow cytometry reagent market. This second round of equity investment, which brought in […]

Funding will support recruitment, commercial partnerships, and further development of Semarion’s SemaCyte cell assaying platform, which turns adherent cells into liquid reagents to enable novel drug screening methodologies Investors include Parkwalk Advisors, University of Cambridge Seed Funds, Martlet Capital, and angel investors Cambridge, UK: Semarion Ltd, a University of Cambridge spin-out company from the Cavendish Laboratory […]

RENO, Nev.— Bioelectronica Corporation (“Bioelectronica”) today announced the closing of an investment by Proxima Ventures and Co-win Ventures to advance the company’s innovations in digital biochemistry, from novel assay development to scalable electrofluidics. The Series A investment was led by Proxima Ventures with follow-on investment by Co-win Ventures. The team at Proxima, experienced investors in […]

Funding will support development of novel proteomic devices based on quantum sensing BOULDER, Colo., October 13, 2020 — SomaLogic, Inc. announced today that a collaborative project between SomaLogic scientists and academic researchers at the University of Chicago, University of California, Los Angeles, University of California, Santa Barbara, and University of Washington, Seattle has received a […]

Seed round led by; Genemod to expand product offering and scale team SEATTLE — Genemod, a software solution for life scientists that uses data automation to streamline and accelerate research, today announced a $1.7M seed funding round led by with added support by Omicron, Unpopular Ventures, Underdog Labs, and Canaan Partners Scout Fund. The funding will enable Genemod to now include a complimentary […]